Failure to Treat Seborrheic Dermatitis
Summary
The facility failed to provide adequate care and services related to skin issues when it did not address and treat a resident’s seborrheic dermatitis on his face and scalp. The resident had multiple diagnoses including acute and chronic respiratory failure with hypoxia, epilepsy, spastic quadriplegic cerebral palsy, seborrheic dermatitis, and dysphagia. His admission MDS showed severely impaired cognition, dependence on staff for all ADLs, risk for pressure ulcer development, and moisture associated skin damage. The care plan directed staff to provide skin inspections every shift, but it did not include direction for seborrheic dermatitis. Hospital discharge information sent to the facility documented a history of seborrheic dermatitis and included treatment recommendations for Vanicream, ketoconazole shampoo, and ketoconazole cream for red areas on the face. The facility’s orders included ketoconazole shampoo and ketoconazole cream, and an order note documented Vanicream was discontinued and A&D ointment was ordered verbally. However, review of the MARs and TARs showed no signatures indicating the resident received ketoconazole cream, ketoconazole shampoo, or A&D ointment. Facility documentation during the stay repeatedly noted skin as warm and pink with no edema, and bath sheets documented no concerns, while progress notes lacked identification of rashes or flaky skin. The resident’s condition was later documented on hospital readmission as a significantly worse fungal facial rash than when he had originally been discharged, with multiple reddened circular areas on the face, yellowed flakes near the nose and eyes, white flakes on the lips and chin, and similar reddened flaky areas on the ear. Interviews showed the resident’s representative had asked staff to wash his face and apply cocoa butter cream daily and had asked about a dermatology visit. Staff interviews reflected that CNAs noticed dry, flaky or irritated skin and notified nurses, while an administrative nurse stated the Vanicream order was discontinued because it was viewed as only for dry skin and that she did not call to clarify the order with the discharging hospital.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release October 8, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.